Literature DB >> 33434076

Is There Still a Role for Allogeneic Transplantation in the Management of Lymphoma?

Nirav N Shah1, Mehdi Hamadani1,2.   

Abstract

Entities:  

Year:  2021        PMID: 33434076     DOI: 10.1200/JCO.20.01447

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Double-refractory Hodgkin lymphoma: tackling relapse after brentuximab vedotin and checkpoint inhibitors.

Authors:  Narendranath Epperla; Mehdi Hamadani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.

Authors:  Alex F Herrera; Kwang Woo Ahn; Carlos Litovich; Yue Chen; Amer Assal; Qaiser Bashir; Ruthee-Lu Bayer; Melanie Coleman; Zachariah DeFilipp; Nosha Farhadfar; Matthew Greenwood; Theresa Hahn; Mitchell Horwitz; Caron Jacobson; Samantha Jaglowski; Sylvie Lachance; Amelia Langston; Bassam Mattar; Richard T Maziarz; Joseph McGuirk; Mohammad A H Mian; Sunita Nathan; Adrienne Phillips; Kevin Rakszawski; Henrik Sengeloev; Shalini Shenoy; Robert Stuart; Craig S Sauter; Mohamed A Kharfan-Dabaja; Mehdi Hamadani
Journal:  Blood Adv       Date:  2021-09-28

3.  Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplant.

Authors:  Malvi Savani; Kwang W Ahn; Yue Chen; Sairah Ahmed; Amanda F Cashen; Mazyar Shadman; Dipenkumar Modi; Farhad Khimani; Corey S Cutler; Jasmine Zain; Jonathan E Brammer; Andrew R Rezvani; Timothy S Fenske; Craig S Sauter; Mohamed A Kharfan-Dabaja; Alex F Herrera; Mehdi Hamadani
Journal:  Br J Haematol       Date:  2022-02-02       Impact factor: 8.615

4.  Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis.

Authors:  Mehdi Hamadani; Ajay K Gopal; Marcelo Pasquini; Soyoung Kim; Xianmiao Qiu; Sairah Ahmed; Aleksandr Lazaryan; Vijaya Raj Bhatt; Andrew Daly; Premal Lulla; Stefan Ciurea; Jordan Gauthier; Vaibhav Agrawal; Natalie S Grover; Lazaros Lekakis; Dipenkumar Modi; Parastoo B Dahi; Megan M Herr; P Connor Johnson; Hamza Hashmi; Peiman Hematti; Frederick L Locke
Journal:  Blood Adv       Date:  2022-01-25

5.  Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics.

Authors:  Mehdi Hamadani; Maud Ngoya; Anna Sureda; Qaiser Bashir; Carlos Alejandro Litovich; Hervé Finel; Yue Chen; Ariane Boumendil; Jasmine Zain; Luca Castagna; Amanda F Cashen; Didier Blaise; Mazyar Shadman; Rocco Pastano; Farhad Khimani; Mutlu Arat; Sascha Dietrich; Norbert Schmitz; Bertram Glass; Mohamed A Kharfan-Dabaja; Paolo Corradini; Craig S Sauter; Silvia Montoto; Mi Kwon; Alex F Herrera; Peter Dreger
Journal:  Blood Adv       Date:  2022-02-08

6.  Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

Authors:  Ebru Erdoğan; Koray Yalçın; Cansu Hemşinlioğlu; Aslıhan Sezgin; Utku Seyis; Derya Dilek Kançağı; Cihan Taştan; Bulut Yurtsever; Raife Dilek Turan; Didem Çakırsoy; Selen Abanuz; Gözde Sır Karakuş; Muhammer Elek; Hüseyin Saffet Bekoz; Ali İhsan Gemici; Deniz Sargın; Mutlu Arat; Burhan Ferhanoğlu; Ebru Pekgüç; Serdar Örnek; Deram Büyüktaş; Nur Birgen; Siret Ratip; Ercüment Ovalı
Journal:  Turk J Haematol       Date:  2022-07-18       Impact factor: 2.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.